OmniSonics Announces Issuance of Three Key U.S. Patents; Claims Cover Removal of Plaque and Occlusions, as Well as Manufacturing Methods, for OmniWave Technology Platform.Business Editors/Health/Medical Writers WILMINGTON, Mass.--(BUSINESS WIRE)--Dec. 9, 2003 OmniSonics Medical Technologies, Inc. announced today that it has recently been granted three U.S. patents covering its OmniWave(TM) Technology platform for treatment of vascular occlusive occlusive /oc·clu·sive/ (o-kloo´siv) pertaining to or causing occlusion. oc·clu·sive adj. 1. Occluding or tending to occlude. 2. disease. U.S. Patent No. 6,660,013, entitled "Apparatus for Removing Plaque from Blood Vessels Blood vessels Tubular channels for blood transport, of which there are three principal types: arteries, capillaries, and veins. Only the larger arteries and veins in the body bear distinct names. Using Ultrasonic Energy," issued December 9, 2003, covers an ultrasonic apparatus for removing plaque from blood vessels. U.S. Patent No. 6,652,547, entitled "Apparatus and Method of Removing Occlusions Using an Ultrasonic Medical Device Operating in a Transverse Mode A transverse mode of a beam of electromagnetic radiation is a particular intensity pattern of radiation measured in a plane perpendicular (i.e. transverse) to the propagation direction of the beam. ," issued November 25, 2003, covers an ultrasonic medical device operating in a transverse mode of vibration for removing vascular occlusions. U.S. Patent No. 6,647,755, entitled "Method for Manufacturing Small Diameter Medical Devices," issued November 18, 2003, covers methods for manufacturing small diameter medical devices, such as ultrasonic probes or wires, for use with the OmniWave Technology platform. The Company has also applied for corresponding international patents to cover each of the U.S. patents. The OmniWave Technology platform forms the technical basis of the Resolution(R) System, which is designed to resolve occlusions which occur as a result of coronary artery disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. , hemodialysis access grafts, deep vein thrombosis A blood clot (thrombos) in a vein deep within the muscle, typically in the thigh or calf. It is caused by disease or the lack of activity such as sitting for hours at a computer screen. and peripheral artery disease. The device, consisting of a thin, titanium wire that is placed into a clogged artery or vein, delivers low power, acoustic energy in all directions to resolve blood clots Blood Clots Definition A blood clot is a thickened mass in the blood formed by tiny substances called platelets. Clots form to stop bleeding, such as at the site of cut. into minute particles approximately the size of red blood cells Red blood cells Cells that carry hemoglobin (the molecule that transports oxygen) and help remove wastes from tissues throughout the body. Mentioned in: Bone Marrow Transplantation red blood cells . "The two patents covering the removal of plaque and the removal of occlusions provide additional protection for OmniSonics' revolutionary approach to the treatment of vascular and other occlusive diseases," said Robert Rabiner, President and Chief Executive Officer of OmniSonics. "The patent covering methods of manufacturing small diameter medical devices strengthens our ability to supply the market with this innovative medical device. OmniSonics' patent portfolio continues to grow, demonstrating the strength of our technical capabilities, as well as our commitment to providing safe and effective solutions for the treatment of occlusive diseases." The OmniWave Technology platform is protected by more than 70 patents and patent applications worldwide. About OmniSonics Medical Technologies, Inc. OmniSonics Medical Technologies, Inc. is a privately held medical device company focused on bringing breakthrough products for vascular occlusive disease to market. These products are based on the Company's patented OmniWave(TM) Technology, the first technology that enables the delivery of acoustic energy over the active length of a small diameter wire in an occluded blood vessel blood vessel n. An elastic tubular channel, such as an artery, a vein, a sinus, or a capillary, through which the blood circulates. blood vessel(s), n the network of muscular tubes that carry blood. . OmniWave Technology is designed to have broad applications in peripheral and coronary vascular occlusive conditions, which afflict af·flict tr.v. af·flict·ed, af·flict·ing, af·flicts To inflict grievous physical or mental suffering on. [Middle English afflighten, from afflight, millions of people worldwide. The Resolution(R) System bears the CE Mark and is available for sale in Europe and Australia. In the U.S., the device is currently in clinical studies and is not commercially available. OmniSonics has been honored by the World Economic Forum as a "Technology Pioneer for 2003" for the innovation of this "radical and transformational" technology and has also been named as one of Fast Company's "Fast 50" Champions of Innovation in 2002. The Company is based in Wilmington, Massachusetts For other towns and places named Wilmington, see Wilmington. Wilmington is a town in Middlesex County, Massachusetts, United States. The population was 21,363 at the 2000 census. . For more information on OmniSonics Medical Technologies, visit the company's Web site at www.omnisonics.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion